A M Stiggelbout
Overview
Explore the profile of A M Stiggelbout including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
2508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stoop T, Seelen L, van t Land F, van der Hout A, Scheepens J, Ali M, et al.
BMC Cancer
. 2025 Feb;
25(1):299.
PMID: 39972248
Background: The introduction of (m)FOLFIRINOX and gemcitabine-nab-paclitaxel has changed the perspective for patients with locally advanced pancreatic cancer (LAPC). Consequently, in experienced centres 23% of patients with LAPC undergo a...
2.
Neve O, Jansen J, van der Mey A, Koot R, de Ridder M, van Benthem P, et al.
Eur Arch Otorhinolaryngol
. 2021 Jul;
279(6):2819-2826.
PMID: 34218308
Background: Employment is an important factor in quality of life. For vestibular schwannoma (VS) patients, employment is not self-evident, because of the sequelae of the disease or its treatment and...
3.
Neve O, Soulier G, Hendriksma M, van der Mey A, van Linge A, van Benthem P, et al.
Eur Arch Otorhinolaryngol
. 2020 Oct;
278(9):3237-3244.
PMID: 33026499
Purpose: In cases of small- to medium-sized vestibular schwannomas, three management strategies can be opted for: active surveillance, surgery or radiotherapy. In these cases, the patient's preference is pivotal in...
4.
Rodenburg-Vandenbussche S, Carlier I, van Vliet I, van Hemert A, Stiggelbout A, Zitman F
Gen Hosp Psychiatry
. 2018 Jul;
54:18-24.
PMID: 30048764
Objective: To investigate treatment selection in a naturalistic sample of MDD outpatients and the factors influencing treatment selection in specialized psychiatric care. Method: Multinomial Logistic Regression analysis investigated associations between...
5.
Hamelinck V, Stiggelbout A, van de Velde C, Liefers G, Bastiaannet E
Eur J Surg Oncol
. 2017 Mar;
43(7):1288-1296.
PMID: 28258786
Purpose: As older women with breast cancer (BC) are underrepresented in trials, it is often unclear what represents the best treatment option for this patient group. To understand how oncologists...
6.
Bakker R, Kenter G, Creutzberg C, Stiggelbout A, Derks M, Mingelen W, et al.
Psychooncology
. 2016 Nov;
26(10):1470-1477.
PMID: 27862635
Background: To assess whether sexual distress among cervical cancer (CC) survivors is associated with frequently reported vaginal sexual symptoms, other proposed biopsychosocial factors and whether worries about painful intercourse mediate...
7.
Louwe L, Stiggelbout A, Overbeek A, Hilders C, van den Berg M, Wendel E, et al.
Eur J Cancer Care (Engl)
. 2016 Oct;
27(1).
PMID: 27774666
Current practices in counselling of female cancer patients with respect to fertility issues need considerable improvement, particularly given the general underuse of fertility preservation options and the negative impact that...
8.
Pieterse A, Kunneman M, Engelhardt E, Brouwer N, Kroep J, Marijnen C, et al.
Psychooncology
. 2016 Aug;
26(7):943-950.
PMID: 27502561
Objectives: To assess the occurrence of questions that foster shared decision making, in particular cancer patients' understanding of treatment decisions and oncologists' understanding of patients' priorities, during consultations in which...
9.
Groenenberg I, Crone M, van Dijk S, Ben Meftah J, Middelkoop B, Assendelft W, et al.
Prev Med Rep
. 2016 Jul;
4:33-43.
PMID: 27413659
Cardiometabolic diseases affect underserved groups disparately. Participation in health checks is also lower, widening health inequalities in society. Two-stage screening (non-invasive health risk assessment (HRA) and GP consultations for high-risk...
10.
Stiggelbout A, Kunneman M, Baas-Thijssen M, Neijenhuis P, Loor A, Jagers S, et al.
Qual Life Res
. 2015 Dec;
25(7):1853-8.
PMID: 26711791
Purpose: To validate the Dutch version of the EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer. Methods: We translated and pilot-tested the original questionnaire in the Netherlands, following EORTC...